- Home
- MVO vs ELUT Comparison
MVO vs ELUT Comparison
Compare MVO & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- ELUT
- Stock Information
- Founded
- MVO 2006
- ELUT 2015
- Country
- MVO United States
- ELUT United States
- Employees
- MVO N/A
- ELUT N/A
- Industry
- MVO Oil & Gas Production
- ELUT Medical Specialities
- Sector
- MVO Energy
- ELUT Health Care
- Exchange
- MVO Nasdaq
- ELUT Nasdaq
- Market Cap
- MVO 66.6M
- ELUT 71.5M
- IPO Year
- MVO N/A
- ELUT 2020
- Fundamental
- Price
- MVO $5.80
- ELUT $1.98
- Analyst Decision
- MVO
- ELUT Strong Buy
- Analyst Count
- MVO 0
- ELUT 2
- Target Price
- MVO N/A
- ELUT $8.00
- AVG Volume (30 Days)
- MVO 55.1K
- ELUT 27.0K
- Earning Date
- MVO 01-01-0001
- ELUT 08-06-2025
- Dividend Yield
- MVO 17.46%
- ELUT N/A
- EPS Growth
- MVO N/A
- ELUT N/A
- EPS
- MVO 1.46
- ELUT N/A
- Revenue
- MVO N/A
- ELUT $23,711,000.00
- Revenue This Year
- MVO N/A
- ELUT $20.10
- Revenue Next Year
- MVO N/A
- ELUT $85.89
- P/E Ratio
- MVO $7.29
- ELUT N/A
- Revenue Growth
- MVO N/A
- ELUT N/A
- 52 Week Low
- MVO $8.85
- ELUT $1.61
- 52 Week High
- MVO $13.95
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- MVO 48.04
- ELUT 49.75
- Support Level
- MVO $5.55
- ELUT $1.70
- Resistance Level
- MVO $5.97
- ELUT $1.99
- Average True Range (ATR)
- MVO 0.23
- ELUT 0.14
- MACD
- MVO -0.01
- ELUT 0.01
- Stochastic Oscillator
- MVO 28.17
- ELUT 38.17
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.